Paper Details

  1. Home
  2. Paper Details

Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study.

Author: BramsMatthew N, ChildressAnn C, CutlerAndrew J, MarraffinoAndrea, OhCharles

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) is a medication used to treat attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older. This study assessed the long-term safety and tolerability of SDX/d-MPH in children with ADHD over a year. The results show that SDX/d-MPH was safe and well-tolerated, comparable to other methylphenidate medications, and showed sustained efficacy over the study period.
Paper Details　
Original Abstract of the Article :
<b><i>Objective</i>:</b> Serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) is approved for the treatment of patients aged &#8805;6 years with attention-deficit/hyperactivity disorder (ADHD). A pivotal double-blind (DB) study of children aged 6-12 years with ADHD demonstrated efficacy for ADHD wi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031142/

データ提供：米国国立医学図書館（NLM）

Serdexmethylphenidate/Dexmethylphenidate: A Safe and Effective Treatment for ADHD

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that affects children and adults. This study focuses on the safety and efficacy of Serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH), a medication used to treat ADHD. The authors conducted a long-term, open-label safety study, evaluating the effects of SDX/d-MPH in children with ADHD for up to a year. The study found that SDX/d-MPH was safe, well-tolerated, and effective in managing ADHD symptoms, providing a promising treatment option for children with this disorder.

Navigating the ADHD Landscape: A Safe and Effective Route

The study results suggest that SDX/d-MPH is a safe and effective treatment for ADHD, offering a potential solution for children struggling with this condition. It's like a camel caravan traversing a challenging desert landscape, finding a reliable and safe path to reach its destination. The study's findings provide valuable information for healthcare providers and families seeking effective treatment options for ADHD.

Supporting Children with ADHD: A Safer Journey

This research emphasizes the importance of finding safe and effective treatments for children with ADHD. Just as a camel caravan relies on its guide to navigate the desert, parents and healthcare providers need reliable information to make informed decisions about ADHD treatment. The study provides evidence that SDX/d-MPH can be a safe and effective option for managing ADHD symptoms, helping children on their journey to a healthier and more fulfilling life.

Dr. Camel's Conclusion

This study offers a glimmer of hope for children struggling with ADHD. It's like discovering a hidden oasis in the vast desert of ADHD research, providing a safe and effective treatment option for children seeking relief from their symptoms. The study's findings contribute to our understanding of ADHD and the development of better treatment strategies.

Date :
  1. Date Completed 2023-03-23
  2. Date Revised 2023-04-03
Further Info :

Pubmed ID

36809150

DOI: Digital Object Identifier

PMC10031142

Related Literature

Article Analysis
・Effects of dexmethylphenidate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.